Aristeia Capital’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History

Aristeia Capital’s Portfolio DMAAR Stock Details DMAAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16K	Sell	264,168 -617,548	-70%	-$65.4K	﹤0.01%	654
2025 Q4	$165K	Hold	881,716	–	–	﹤0.01%	432
2025 Q3	$192K	Sell	881,716 -6,118	-0.7%	-$1.14K	0.01%	389
2025 Q2	$107K	Sell	887,834 -12,166	-1%	-$1.56K	﹤0.01%	387
2025 Q1	$117K	Buy	+900,000	New	+$126K	﹤0.01%	335

Other funds holding DMAAR

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return